COMPANY PROFILE

Seed Therapeutics

Explore full profile

Pioneering the science of improving human health

New York City, United StatesFounded 2019Biotech & Life Sciences

Valuation $100–250M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Seed Therapeutics

Seed Therapeutics is a pioneering biotech company focused on developing novel therapies that degrade disease-causing proteins, particularly those that have been difficult to target with traditional small molecule drugs. The company operates in the biopharmaceutical market, primarily serving patients with cancer and other serious diseases. Seed Therapeutics collaborates with leading research institutions and pharmaceutical companies, such as Lilly, to advance its drug candidates towards clinical and commercial success. The business model involves research and development of proprietary drug candidates, followed by licensing agreements and partnerships to bring these therapies to market. Revenue is generated through milestone payments, royalties, and licensing fees from these collaborations.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2019
Headquarters: New York City, United States
Employees: 25
Open positions: None listed
Dealroom signal: 85.6/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, proteomics, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Aug 2025	$6M	$120M	Undisclosed	↗
SECONDARY✓Other financing	Jan 2025	$35M	—	Undisclosed	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Seed Therapeutics website traffic

Latest recorded traffic for Seed Therapeutics is 2.6K monthly website visits, up 100% over the last three months. Seed Therapeutics's team grew 56.3% over the past year.

Latest monthly visits2.6K 3-month web change+100% 1-year team growth+56.3%

Monthly website visitsOct 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OTOlatec TherapeuticsLeaders in the Clinical Development of Inflammasome Therapeutics	New York City, United States	Operational	14	$102M	$160M
DTDICE TherapeuticsDeveloping transformative medicines for autoimmune and inflammatory diseases	South San Francisco, United States	Acquired
MDMass DynamicsMass Dynamics exists to equip proteomics and discovery scientists with simple and rapid ways to dissect complex questions in human disease, leading to the acceleration of discoveries	Melbourne, Australia	Operational
CACantargiaDevelops a therapy for the treatment of cancer by targeting a unique cell-surface receptor on malignant stem cells	Lund Municipality, Sweden	Operational
MAMatchpointDesigning a new era of precision covalent medicines informed by breakthroughs in ultradeep chemoproteomics and machine learning	Boston, United States	Operational
SESepternaBiotechnology company discovering and advancing novel small molecule medicines targeting G protein-coupled receptors (GPCRs)	San Francisco, United States	Operational
RORadionetics OncologyRadionetics Oncology is a precision oncology company focusing on the discovery and development of radiopharmaceuticals	San Diego, United States	Operational
STStratus TherapeuticsDeveloping off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases	Natick, United States	Operational